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Until now, 15 different serotypes of Actinobacillus pleuropneumoniae (Ap) have been described 
based upon differences in the capsular polysaccharides of the bacterium. The virulence of different 
serotypes of Ap has been experimentally determined and the differences in mortality and morbidity 
are considerable. The genetic mechanisms behind these variations in virulence are largely unknown, 
and for bacteria in general, the non-virulent strains often contain many of the virulence genes 
required for an infection. In Denmark, serotype 2 and serotype 6 are the most commonly found, 
with serotype 2 being of high virulence while serotype 6 strains are normally found to be less 
pathogenic. To gain an understanding of the differential virulence of serotype 2 and 6, the 
expression of a panel of Ap genes during infection of porcine epithelial lung cells (SJPL) were 
examined by quantitative real-time PCR (qPCR). Flasks of SJPL cells were inoculated with equal 
amounts of Ap serotype 2 and 6, respectively. After two hours, the supernatant was discarded, the 
cells and attached bacteria harvested, and total RNA isolated. After an enrichment step for bacterial 
RNA, the expression of a number of Ap genes believed to be important for early establishment of 
the bacteria in the host were examined by qPCR. Three previously validated reference genes, glyA, 
pykA and tpiA were included for normalization of the qPCR data. Among the eight genes compared, 
three appeared to be significantly differently expressed. In serotype 6, the genes cpxB and kdsB, 
both involved in capsule formation, were upregulated compared to serotype 2. In serotype 2, the 
production of pgaB, involved in biofilm formation, seem negligible in comparison to serotype 6. 
However, more data is needed on this particular gene. Still, this result is in agreement with 
observations in the laboratory, where biofilm formation is observed for some strains of serotype 6. 
Interestingly, in serotype 2, the toxin gene apxII appears to be significantly upregulated compared 
to serotype 6, which is in accordance with the observed difference in pathogenicity. However, 
further investigations will be needed to establish whether these results have any relevance to the 
difference in virulence. Results from this study will be used as the basis for a microarray approach 
to examine the overall gene expression variation between Ap serotypes in vitro and in vivo. 
 
 
 
 
 
 
